Pilot 2: Watchful Living: A lifestyle intervention for black prostate cancer patients on active surveillance and their partners
Pilot 2: Watchful Living: A lifestyle intervention for black prostate cancer patients on active surveillance and their partners
批准号:
9418230
负责人:
Dalnim Cho
金额:
$4.36万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-22 至 2021-08-31
关键词:
AddressAnxietyAreaBasenBehaviorBehavioralBiometryBody mass indexCancer CenterCancer InterventionCancer PatientCancer SurvivorCaregiversChronicChronic DiseaseClinicalCollaborationsContinuity of Patient CareCounselingCouplesDataDetectionDiagnosisDietDietitianDiseaseEvaluationFeedbackFocus GroupsFundingGoalsHealthHome environmentHospitalsIncidenceInflammationInflammatoryIntakeInterventionLife StyleMalignant NeoplasmsMalignant neoplasm of prostateMonitorMorbidity - disease rateParticipantPathway interactionsPatient RecruitmentsPatientsPhysical activityPlayPopulationProcessProstate-Specific AntigenQuality of lifeRecruitment ActivityResearchResearch PersonnelRiskRoleSecond Primary CancersSocial supportSourceSpousesTelephoneTestingTherapeutic InterventionUniversitiesUniversity of Texas M D Anderson Cancer Centerbasebehavior changecancer carecancer health disparityclinical biomarkersclinically significantcomorbiditycopingdesignexercise prescriptionexperiencefruits and vegetablesimprovedinflammatory markerinnovationlifestyle interventionmenmortalitynutritionpreventprogramssatisfactionscreeningtertiary prevention
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The burden of prostate cancer in the U.S. is large: an estimated 14% of men will be diagnosed with prostate
cancer during their lifetime. There are approximately three million prostate cancer survivors in the U.S., and
the burden is highest among black men, for whom incidence and mortality rates are 169.4 and 69.0 per
100,000, respectively. The introduction of prostate-specific antigen screening has resulted in detection of more
cases of prostate cancer, although many of these cases are asymptomatic and may not progress to clinical
significance. Active surveillance is a management option for low-risk prostate cancer patients, during which the
disease is actively monitored. Active surveillance patients are an ideal population for lifestyle interventions,
which may improve diet and physical activity, reduce body mass index, and improve clinical biomarkers, thus
reducing risk of other chronic conditions and second primary cancers and improving patients' quality of life.
Thus far, several lifestyle interventions for patients undergoing active surveillance have had positive results;
however, none have targeted spouses or partners, or black men, in their design and implementation. The
proposed study seeks to pilot test Watchful Living, an innovative, culturally-relevant social support lifestyle
intervention during active surveillance for black prostate cancer patients and their partners. Our specific aims
are: 1) To determine the feasibility of recruiting and implementing a lifestyle intervention during active
surveillance for prostate cancer patients and their partners, 2) To evaluate preliminary efficacy of an active
surveillance lifestyle intervention in improving diet, physical activity, quality of life, and inflammation at the
end of the study (Month 6), and 3) To conduct a process evaluation of the active surveillance lifestyle
intervention. We will recruit 40 patient-partner dyads from MD Anderson Cancer Center and Lyndon B.
Johnson Hospital, who will receive dyadic telephone coaching, exercise prescriptions in a home-based physical
activity program, nutrition counseling with a registered dietitian, and educational handouts. Watchful Living
has the potential to ultimately prevent morbidity and mortality due to prostate cancer by significantly reducing
chronic diseases and second primary cancers, and improving the quality of life of black patients and their
partners. Pilot funding is critical to demonstrating the feasibility and preliminary efficacy of our intervention.
With this pilot data, we will apply for an R01 to adapt, implement, and evaluate the intervention on a larger
scale.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Randomized controlled trial to test feasibility of a culturally adapted meditation-based support intervention for Black patients dealing with advanced cancer
-
批准号:10648212
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2023
-
负责人:Dalnim Cho
-
依托单位:
海外基金